|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7105 | |
| A61P 35/00 | |||
| C12N 15/11 |
| (11) | Number of the document | 2217248 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08844596.0 |
| Date of filing the European patent application | 2008-10-29 | |
| (97) | Date of publication of the European application | 2010-08-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/081645 |
| Date | 2008-10-29 |
| (87) | Number | WO 2009/058907 |
| Date | 2009-05-07 |
| (30) | Number | Date | Country code |
| 983231 P | 2007-10-29 | US |
| (72) |
BENNETT, C., Frank, US
CHAJUT, Ayelet, IL
ESAU, Christine, US
MARCUSSON, Eric, G., US
YERUSHALMI, Noga, IL
|
| (73) |
Regulus Therapeutics Inc.,
10614 Science Center Drive, San Diego, CA 92121,
US
Rosetta Genomics Ltd., 10 Plaut Street, 76706 Rehovot, IL |
| (54) | TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER |
| TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER |